APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gene Service Market Outlook and Growth Opportunities 2026

30 January 2026192 pages

Choose your research edition.

Industry ResearchGene Service Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Service Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Gene Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Service Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gene Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gene Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gene Service market include LipExoGen Biotech, Synbio Technologies, Genscript Biotech Corporation, Creative Biogene, GENEWIZ, Bio-Techne, Charles River Laboratories, Geneservice and Boston Medical Center, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gene Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Service market.

Gene Service Segment by Company

LipExoGen Biotech

Synbio Technologies

Genscript Biotech Corporation

Creative Biogene

GENEWIZ

Bio-Techne

Charles River Laboratories

Geneservice

Boston Medical Center

DefiGEN

NHS England

Integrated DNA Technologies

Blossom

Aldevron

Biocytogen

Gene Service Segment by Type

Gene Synthesis

Gene Cloning

Gene Mutagenesis

Gene Regulation

Gene Service Segment by Application

Medical

Biological

Gene Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gene Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gene Service key companies, revenue, market share, and recent developments.

3. To split the Gene Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gene Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gene Service significant trends, drivers, influence factors in global and regions.

6. To analyze Gene Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Service industry.

Chapter 3: Detailed analysis of Gene Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gene Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gene Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gene Service Industry Trends Table 2. Gene Service Industry Drivers Table 3. Gene Service Industry Opportunities and Challenges Table 4. Gene Service Industry Restraints Table 5. Global Gene Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gene Service Revenue Share by Company (2021-2026) Table 7. Global Gene Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gene Service Key Company Manufacturing Base & Headquarters Table 9. Global Gene Service Company, Product Type & Application Table 10. Global Gene Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gene Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Synthesis Table 15. Significant Companies of Gene Cloning Table 16. Significant Companies of Gene Mutagenesis Table 17. Significant Companies of Gene Regulation Table 18. Global Gene Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Gene Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Gene Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Gene Service Sales Value Share by Type (2021-2026) Table 22. Global Gene Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Medical Table 24. Significant Companies of Biological Table 25. Global Gene Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Gene Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Gene Service Sales Value Share by Application (2021-2026) Table 29. Global Gene Service Sales Value Share by Application (2027-2032) Table 30. Global Gene Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Gene Service Sales Value Share by Region (2021-2026) Table 33. Global Gene Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Gene Service Sales Value Share by Region (2027-2032) Table 35. Global Gene Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gene Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Gene Service Sales Value Market Share by Country (2021-2026) Table 38. Global Gene Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Gene Service Sales Value Market Share by Country (2027-2032) Table 40. LipExoGen Biotech Company Information Table 41. LipExoGen Biotech Business Overview Table 42. LipExoGen Biotech Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. LipExoGen Biotech Gene Service Product Portfolio Table 44. LipExoGen Biotech Recent Development Table 45. Synbio Technologies Company Information Table 46. Synbio Technologies Business Overview Table 47. Synbio Technologies Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Synbio Technologies Gene Service Product Portfolio Table 49. Synbio Technologies Recent Development Table 50. Genscript Biotech Corporation Company Information Table 51. Genscript Biotech Corporation Business Overview Table 52. Genscript Biotech Corporation Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Genscript Biotech Corporation Gene Service Product Portfolio Table 54. Genscript Biotech Corporation Recent Development Table 55. Creative Biogene Company Information Table 56. Creative Biogene Business Overview Table 57. Creative Biogene Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Creative Biogene Gene Service Product Portfolio Table 59. Creative Biogene Recent Development Table 60. GENEWIZ Company Information Table 61. GENEWIZ Business Overview Table 62. GENEWIZ Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. GENEWIZ Gene Service Product Portfolio Table 64. GENEWIZ Recent Development Table 65. Bio-Techne Company Information Table 66. Bio-Techne Business Overview Table 67. Bio-Techne Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bio-Techne Gene Service Product Portfolio Table 69. Bio-Techne Recent Development Table 70. Charles River Laboratories Company Information Table 71. Charles River Laboratories Business Overview Table 72. Charles River Laboratories Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Charles River Laboratories Gene Service Product Portfolio Table 74. Charles River Laboratories Recent Development Table 75. Geneservice Company Information Table 76. Geneservice Business Overview Table 77. Geneservice Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Geneservice Gene Service Product Portfolio Table 79. Geneservice Recent Development Table 80. Boston Medical Center Company Information Table 81. Boston Medical Center Business Overview Table 82. Boston Medical Center Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Boston Medical Center Gene Service Product Portfolio Table 84. Boston Medical Center Recent Development Table 85. DefiGEN Company Information Table 86. DefiGEN Business Overview Table 87. DefiGEN Gene Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. DefiGEN Gene Service Product Portfolio Table 89. DefiGEN Recent Development Table 90. NHS England Company Information Table 91. NHS England Business Overview Table 92. NHS England Gene Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. NHS England Gene Service Product Portfolio Table 94. NHS England Recent Development Table 95. Integrated DNA Technologies Company Information Table 96. Integrated DNA Technologies Business Overview Table 97. Integrated DNA Technologies Gene Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Integrated DNA Technologies Gene Service Product Portfolio Table 99. Integrated DNA Technologies Recent Development Table 100. Blossom Company Information Table 101. Blossom Business Overview Table 102. Blossom Gene Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Blossom Gene Service Product Portfolio Table 104. Blossom Recent Development Table 105. Aldevron Company Information Table 106. Aldevron Business Overview Table 107. Aldevron Gene Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Aldevron Gene Service Product Portfolio Table 109. Aldevron Recent Development Table 110. Biocytogen Company Information Table 111. Biocytogen Business Overview Table 112. Biocytogen Gene Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Biocytogen Gene Service Product Portfolio Table 114. Biocytogen Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Gene Service Product Image Figure 2. Global Gene Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Gene Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Synthesis Image Figure 8. Gene Cloning Image Figure 9. Gene Mutagenesis Image Figure 10. Gene Regulation Image Figure 11. Global Gene Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Gene Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Gene Service Sales Value Share by Type (2021-2032) Figure 14. Medical Image Figure 15. Biological Image Figure 16. Global Gene Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gene Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Gene Service Sales Value Share by Application (2021-2032) Figure 19. Global Gene Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Gene Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Gene Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Gene Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Gene Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Gene Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Gene Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Gene Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Gene Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Gene Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Gene Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Gene Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Gene Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Gene Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Gene Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Synthesis
  • Gene Cloning
  • Gene Mutagenesis
  • Gene Regulation
Applications
  • Medical
  • Biological
Companies covered
  • LipExoGen Biotech
  • Synbio Technologies
  • Genscript Biotech Corporation
  • Creative Biogene
  • GENEWIZ
  • Bio-Techne
  • Charles River Laboratories
  • Geneservice
  • Boston Medical Center
  • DefiGEN
  • NHS England
  • Integrated DNA Technologies
  • Blossom
  • Aldevron
  • Biocytogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gene Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gene Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gene Service Market Dynamics
  1. 2.1 Gene Service Industry Trends
  2. 2.2 Gene Service Industry Drivers
  3. 2.3 Gene Service Industry Opportunities and Challenges
  4. 2.4 Gene Service Industry Restraints
3 Gene Service Market by Company
  1. 3.1 Global Gene Service Company Revenue Ranking in 2025
  2. 3.2 Global Gene Service Revenue by Company (2021-2026)
  3. 3.3 Global Gene Service Company Ranking (2024-2026)
  4. 3.4 Global Gene Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Gene Service Company Product Type and Application
  6. 3.6 Global Gene Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gene Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gene Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gene Service Market by Type
  1. 4.1 Gene Service Type Introduction
  2. 4.1.1 Gene Synthesis
  3. 4.1.2 Gene Cloning
  4. 4.1.3 Gene Mutagenesis
  5. 4.1.4 Gene Regulation
  6. 4.2 Global Gene Service Sales Value by Type
  7. 4.2.1 Global Gene Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gene Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Gene Service Sales Value Share by Type (2021-2032)
5 Gene Service Market by Application
  1. 5.1 Gene Service Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Biological
  4. 5.2 Global Gene Service Sales Value by Application
  5. 5.2.1 Global Gene Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gene Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Gene Service Sales Value Share by Application (2021-2032)
6 Gene Service Regional Value Analysis
  1. 6.1 Global Gene Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gene Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gene Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gene Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gene Service Sales Value (2021-2032)
  7. 6.3.2 North America Gene Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gene Service Sales Value (2021-2032)
  10. 6.4.2 Europe Gene Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gene Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gene Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gene Service Sales Value (2021-2032)
  16. 6.6.2 South America Gene Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gene Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gene Service Sales Value Share by Country, 2025 VS 2032
7 Gene Service Country-level Value Analysis
  1. 7.1 Global Gene Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gene Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gene Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gene Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gene Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gene Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gene Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gene Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gene Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gene Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gene Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gene Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gene Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gene Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gene Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gene Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gene Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gene Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gene Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gene Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gene Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gene Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gene Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gene Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gene Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gene Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gene Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gene Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gene Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gene Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gene Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gene Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gene Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gene Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gene Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gene Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gene Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gene Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gene Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gene Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gene Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gene Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gene Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gene Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gene Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gene Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gene Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gene Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gene Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gene Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gene Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gene Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gene Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gene Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gene Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gene Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gene Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gene Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gene Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gene Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gene Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gene Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gene Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gene Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gene Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gene Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gene Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gene Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gene Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gene Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gene Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gene Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gene Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gene Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gene Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gene Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gene Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gene Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gene Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gene Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gene Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gene Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gene Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gene Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gene Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gene Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gene Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gene Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 LipExoGen Biotech
  2. 8.1.1 LipExoGen Biotech Company Information
  3. 8.1.2 LipExoGen Biotech Business Overview
  4. 8.1.3 LipExoGen Biotech Gene Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 LipExoGen Biotech Gene Service Product Portfolio
  6. 8.1.5 LipExoGen Biotech Recent Developments
  7. 8.2 Synbio Technologies
  8. 8.2.1 Synbio Technologies Company Information
  9. 8.2.2 Synbio Technologies Business Overview
  10. 8.2.3 Synbio Technologies Gene Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Synbio Technologies Gene Service Product Portfolio
  12. 8.2.5 Synbio Technologies Recent Developments
  13. 8.3 Genscript Biotech Corporation
  14. 8.3.1 Genscript Biotech Corporation Company Information
  15. 8.3.2 Genscript Biotech Corporation Business Overview
  16. 8.3.3 Genscript Biotech Corporation Gene Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genscript Biotech Corporation Gene Service Product Portfolio
  18. 8.3.5 Genscript Biotech Corporation Recent Developments
  19. 8.4 Creative Biogene
  20. 8.4.1 Creative Biogene Company Information
  21. 8.4.2 Creative Biogene Business Overview
  22. 8.4.3 Creative Biogene Gene Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Creative Biogene Gene Service Product Portfolio
  24. 8.4.5 Creative Biogene Recent Developments
  25. 8.5 GENEWIZ
  26. 8.5.1 GENEWIZ Company Information
  27. 8.5.2 GENEWIZ Business Overview
  28. 8.5.3 GENEWIZ Gene Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GENEWIZ Gene Service Product Portfolio
  30. 8.5.5 GENEWIZ Recent Developments
  31. 8.6 Bio-Techne
  32. 8.6.1 Bio-Techne Company Information
  33. 8.6.2 Bio-Techne Business Overview
  34. 8.6.3 Bio-Techne Gene Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Techne Gene Service Product Portfolio
  36. 8.6.5 Bio-Techne Recent Developments
  37. 8.7 Charles River Laboratories
  38. 8.7.1 Charles River Laboratories Company Information
  39. 8.7.2 Charles River Laboratories Business Overview
  40. 8.7.3 Charles River Laboratories Gene Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Charles River Laboratories Gene Service Product Portfolio
  42. 8.7.5 Charles River Laboratories Recent Developments
  43. 8.8 Geneservice
  44. 8.8.1 Geneservice Company Information
  45. 8.8.2 Geneservice Business Overview
  46. 8.8.3 Geneservice Gene Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Geneservice Gene Service Product Portfolio
  48. 8.8.5 Geneservice Recent Developments
  49. 8.9 Boston Medical Center
  50. 8.9.1 Boston Medical Center Company Information
  51. 8.9.2 Boston Medical Center Business Overview
  52. 8.9.3 Boston Medical Center Gene Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boston Medical Center Gene Service Product Portfolio
  54. 8.9.5 Boston Medical Center Recent Developments
  55. 8.10 DefiGEN
  56. 8.10.1 DefiGEN Company Information
  57. 8.10.2 DefiGEN Business Overview
  58. 8.10.3 DefiGEN Gene Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DefiGEN Gene Service Product Portfolio
  60. 8.10.5 DefiGEN Recent Developments
  61. 8.11 NHS England
  62. 8.11.1 NHS England Company Information
  63. 8.11.2 NHS England Business Overview
  64. 8.11.3 NHS England Gene Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NHS England Gene Service Product Portfolio
  66. 8.11.5 NHS England Recent Developments
  67. 8.12 Integrated DNA Technologies
  68. 8.12.1 Integrated DNA Technologies Company Information
  69. 8.12.2 Integrated DNA Technologies Business Overview
  70. 8.12.3 Integrated DNA Technologies Gene Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Integrated DNA Technologies Gene Service Product Portfolio
  72. 8.12.5 Integrated DNA Technologies Recent Developments
  73. 8.13 Blossom
  74. 8.13.1 Blossom Company Information
  75. 8.13.2 Blossom Business Overview
  76. 8.13.3 Blossom Gene Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Blossom Gene Service Product Portfolio
  78. 8.13.5 Blossom Recent Developments
  79. 8.14 Aldevron
  80. 8.14.1 Aldevron Company Information
  81. 8.14.2 Aldevron Business Overview
  82. 8.14.3 Aldevron Gene Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aldevron Gene Service Product Portfolio
  84. 8.14.5 Aldevron Recent Developments
  85. 8.15 Biocytogen
  86. 8.15.1 Biocytogen Company Information
  87. 8.15.2 Biocytogen Business Overview
  88. 8.15.3 Biocytogen Gene Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biocytogen Gene Service Product Portfolio
  90. 8.15.5 Biocytogen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst